Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
2.570
-0.110 (-4.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.590
+0.020 (0.78%)
After-hours: Apr 28, 2026, 7:44 PM EDT
Replimune Group Employees
Replimune Group had 479 employees as of March 31, 2025. The number of employees increased by 148 or 44.71% compared to the previous year.
Employees
479
Change (1Y)
148
Growth (1Y)
44.71%
Revenue / Employee
n/a
Profits / Employee
-$657,313
Market Cap
212.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| Keros Therapeutics | 78 |
| Camp4 Therapeutics | 48 |
| ALX Oncology Holdings | 43 |
| Milestone Pharmaceuticals | 38 |
| Enlivex | 34 |
REPL News
- 6 days ago - US Health Secretary Kennedy distances himself from FDA's Replimune cancer drug rejection - Reuters
- 15 days ago - FDA Rejection Sparks Questions On Replimune Drug Approval Path - Benzinga
- 18 days ago - Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma - GlobeNewsWire
- 18 days ago - US FDA declines to approve Replimune's drug for advanced skin cancer - Reuters
- 7 weeks ago - Replimune Group Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Replimune to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Replimune Group Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts